Skip to main content
NCBI home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1997 Apr;10(2):345–357. doi: 10.1128/cmr.10.2.345

Management of listeriosis.

H Hof 1, T Nichterlein 1, M Kretschmar 1
PMCID: PMC172923  PMID: 9105758

Abstract

Determination of the MIC in vitro is often used as the basis for predicting the clinical efficacy of antibiotics. Listeriae are uniformly susceptible in vitro to most common antibiotics except cephalosporins and fosfomycin. However, the clinical outcome is poor. This is partially because listeriae are refractory to the bactericidal mechanisms of many antibiotics, especially to ampicillin-amoxicillin, which still is regarded as the drug of choice. A true synergism can be achieved by adding gentamicin. Another point is that listeriae are able to reside and multiply within host cells, e.g., macrophages, hepatocytes, and neurons, where they are protected from antibiotics in the extracellular fluid. Only a few agents penetrate, accumulate, and reach the cytosol of host cells, where the listeriae are found. Furthermore, certain host cells may exclude antibiotics from any intracellular compartment. Thus, determination of the antibacterial efficacy of a drug against listeriae in cell cultures may be a better approximation of potential therapeutic value. Certain host cells may have acquired the property of excluding certain antibiotics, for example macrolides, from intracellular spaces, which might explain therapeutic failures of antibiotic therapy in spite of low MICs. Animal models do not completely imitate human listeriosis, which is characterized by meningitis, encephalitis, soft tissue and parenchymal infections, and bacteremia. Meningitis produced in rabbits is a hyperacute disease, whereby most listeriae lie extracellularly, fairly accessible to antibiotics that can cross the blood-cerebrospinal fluid barrier. In the murine model of systemic infection, Listeria monocytogenes is located mainly within macrophages and parenchymal cells of the spleen and liver, hardly accessible to certain drugs, such as ampicillin and gentimicin. The therapeutic efficacy of drugs clearly depends on the model used. Thus, for example, the combination of ampicillin with gentamicin acts synergistically in the rabbit meningitis model but not in the mouse model. Since conventional antimicrobial therapy with antibiotics is not satisfactory, particularly in the immunocompromised host (about 30% of patients with listeriosis die in spite of a rational choice of antibiotics), other possibilities must be considered for therapy as well as prevention. Indeed, listeriae are highly susceptible to several endogenous antibiotics, such as defensins. Bacteriocins produced by related bacterial species, e.g., lactobacilli and enterococci, are rapidly bactericidal. However, unfortunately, the use of such alternative measures along with immunization and immunmodulation is not yet feasible.

Full Text

The Full Text of this article is available as a PDF (418.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asensi V., Fierer J. Synergistic effect of human lysozyme plus ampicillin or beta-lysin on the killing of Listeria monocytogenes. J Infect Dis. 1991 Mar;163(3):574–578. doi: 10.1093/infdis/163.3.574. [DOI] [PubMed] [Google Scholar]
  2. Azimi P. H., Koranyi K., Lindsey K. D. Listeria monocytogens: synergistic effects of ampicillin and gentamicin. Am J Clin Pathol. 1979 Dec;72(6):974–977. doi: 10.1093/ajcp/72.6.974. [DOI] [PubMed] [Google Scholar]
  3. Bakker-Woudenberg I. A., Lokerse A. F., Roerdink F. H., Regts D., Michel M. F. Free versus liposome-entrapped ampicillin in treatment of infection due to Listeria monocytogenes in normal and athymic (nude) mice. J Infect Dis. 1985 May;151(5):917–924. doi: 10.1093/infdis/151.5.917. [DOI] [PubMed] [Google Scholar]
  4. Baldassarre J. S., Ingerman M. J., Nansteel J., Santoro J. Development of Listeria meningitis during vancomycin therapy: a case report. J Infect Dis. 1991 Jul;164(1):221–222. doi: 10.1093/infdis/164.1.221. [DOI] [PubMed] [Google Scholar]
  5. Bauer J., Hof H., Nichterlein T., Wuenscher M. Comparative activities of macrolide derivatives on murine listeriosis. Zentralbl Bakteriol. 1993 Feb;278(1):112–119. doi: 10.1016/s0934-8840(11)80284-7. [DOI] [PubMed] [Google Scholar]
  6. Becq-Giraudon B., Breux J. P. Traitement des listérioses neuro-méningées du sujet âgé de plus de soixante ans par l'association ampicilline + sulfaméthoxazole triméthoprime. Pathol Biol (Paris) 1987 May;35(5):626–628. [PubMed] [Google Scholar]
  7. Beerens H., Tahon-Castel M. M. Milieu à l'acide nalidixique pour l'isolement des streptocoques, D. pneumoniae, listeria, erysipelothrix. Ann Inst Pasteur (Paris) 1966 Jul;111(1):90–93. [PubMed] [Google Scholar]
  8. Berner R., Hof H. Therapeutic activity of teicoplanin on experimental listeriosis compared with that of vancomycin and ampicillin. Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Mar;268(1):50–56. doi: 10.1016/s0176-6724(88)80114-7. [DOI] [PubMed] [Google Scholar]
  9. Blatt S. P., Zajac R. A. Treatment of Listeria bacteremia with vancomycin. Rev Infect Dis. 1991 Jan-Feb;13(1):181–182. doi: 10.1093/clinids/12.5.181. [DOI] [PubMed] [Google Scholar]
  10. Boisivon A., Guiomar C., Carbon C. In vitro bactericidal activity of amoxicillin, gentamicin, rifampicin, ciprofloxacin and trimethoprim-sulfamethoxazole alone or in combination against Listeria monocytogenes. Eur J Clin Microbiol Infect Dis. 1990 Mar;9(3):206–209. doi: 10.1007/BF01963839. [DOI] [PubMed] [Google Scholar]
  11. Cao C. X., Silverstein S. C., Neu H. C., Steinberg T. H. J774 macrophages secrete antibiotics via organic anion transporters. J Infect Dis. 1992 Feb;165(2):322–328. doi: 10.1093/infdis/165.2.322. [DOI] [PubMed] [Google Scholar]
  12. Charpentier E., Gerbaud G., Jacquet C., Rocourt J., Courvalin P. Incidence of antibiotic resistance in Listeria species. J Infect Dis. 1995 Jul;172(1):277–281. doi: 10.1093/infdis/172.1.277. [DOI] [PubMed] [Google Scholar]
  13. Cherubin C. E., Appleman M. D., Heseltine P. N., Khayr W., Stratton C. W. Epidemiological spectrum and current treatment of listeriosis. Rev Infect Dis. 1991 Nov-Dec;13(6):1108–1114. doi: 10.1093/clinids/13.6.1108. [DOI] [PubMed] [Google Scholar]
  14. Doucet-Populaire F., Trieu-Cuot P., Dosbaa I., Andremont A., Courvalin P. Inducible transfer of conjugative transposon Tn1545 from Enterococcus faecalis to Listeria monocytogenes in the digestive tracts of gnotobiotic mice. Antimicrob Agents Chemother. 1991 Jan;35(1):185–187. doi: 10.1128/aac.35.1.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Drevets D. A., Canono B. P., Leenen P. J., Campbell P. A. Gentamicin kills intracellular Listeria monocytogenes. Infect Immun. 1994 Jun;62(6):2222–2228. doi: 10.1128/iai.62.6.2222-2228.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Dryden M. S., Jones N. F., Phillips I. Vancomycin therapy failure in Listeria monocytogenes peritonitis in a patient on continuous ambulatory peritoneal dialysis. J Infect Dis. 1991 Dec;164(6):1239–1239. doi: 10.1093/infdis/164.6.1239. [DOI] [PubMed] [Google Scholar]
  17. Edmiston C. E., Jr, Gordon R. C. Evaluation of gentamicin and penicillin as a synergistic combination in experimental murine listeriosis. Antimicrob Agents Chemother. 1979 Dec;16(6):862–863. doi: 10.1128/aac.16.6.862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ehlert F., Neu H. C. In vitro activity of LY146032 (daptomycin), a new peptolide. Eur J Clin Microbiol. 1987 Feb;6(1):84–90. doi: 10.1007/BF02097208. [DOI] [PubMed] [Google Scholar]
  19. Eliopoulos G. M., Moellering R. C., Jr Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside. Antimicrob Agents Chemother. 1981 May;19(5):789–793. doi: 10.1128/aac.19.5.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Facinelli B., Giovanetti E., Varaldo P. E., Casolari P., Fabio U. Antibiotic resistance in foodborne Listeria. Lancet. 1991 Nov 16;338(8777):1272–1272. doi: 10.1016/0140-6736(91)92138-r. [DOI] [PubMed] [Google Scholar]
  21. Gellin B. G., Broome C. V. Listeriosis. JAMA. 1989 Mar 3;261(9):1313–1320. [PubMed] [Google Scholar]
  22. Gentschev I., Sokolovic Z., Köhler S., Krohne G. F., Hof H., Wagner J., Goebel W. Identification of p60 antibodies in human sera and presentation of this listerial antigen on the surface of attenuated salmonellae by the HlyB-HlyD secretion system. Infect Immun. 1992 Dec;60(12):5091–5098. doi: 10.1128/iai.60.12.5091-5098.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Goldstein L. J., Galski H., Fojo A., Willingham M., Lai S. L., Gazdar A., Pirker R., Green A., Crist W., Brodeur G. M. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst. 1989 Jan 18;81(2):116–124. doi: 10.1093/jnci/81.2.116. [DOI] [PubMed] [Google Scholar]
  24. Gottesman M. M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 1993;62:385–427. doi: 10.1146/annurev.bi.62.070193.002125. [DOI] [PubMed] [Google Scholar]
  25. Groisman E. A. How bacteria resist killing by host-defense peptides. Trends Microbiol. 1994 Nov;2(11):444–449. doi: 10.1016/0966-842x(94)90802-8. [DOI] [PubMed] [Google Scholar]
  26. Günther G., Philipson A. Oral trimethoprim as follow-up treatment of meningitis caused by Listeria monocytogenes. Rev Infect Dis. 1988 Jan-Feb;10(1):53–55. doi: 10.1093/clinids/10.1.53. [DOI] [PubMed] [Google Scholar]
  27. Hadorn K., Hächler H., Schaffner A., Kayser F. H. Genetic characterization of plasmid-encoded multiple antibiotic resistance in a strain of Listeria monocytogenes causing endocarditis. Eur J Clin Microbiol Infect Dis. 1993 Dec;12(12):928–937. doi: 10.1007/BF01992167. [DOI] [PubMed] [Google Scholar]
  28. Hakenbeck R., Hof H. Relatedness of penicillin-binding proteins from various Listeria species. FEMS Microbiol Lett. 1991 Nov 15;68(2):191–195. doi: 10.1016/0378-1097(91)90126-u. [DOI] [PubMed] [Google Scholar]
  29. Hiemstra P. S., Eisenhauer P. B., Harwig S. S., van den Barselaar M. T., van Furth R., Lehrer R. I. Antimicrobial proteins of murine macrophages. Infect Immun. 1993 Jul;61(7):3038–3046. doi: 10.1128/iai.61.7.3038-3046.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Hodinka R. L., Jack-Wait K., Wannamaker N., Walden T. P., Gilligan P. H. Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial. Eur J Clin Microbiol. 1987 Feb;6(1):100–103. doi: 10.1007/BF02097211. [DOI] [PubMed] [Google Scholar]
  31. Hof H., Emmerling P. Murine model for therapy of listeriosis in the compromised host. III. The effect of rifampicin. Chemotherapy. 1984;30(2):125–130. doi: 10.1159/000238258. [DOI] [PubMed] [Google Scholar]
  32. Hof H. Failure of recombinant murine gamma-interferon to cure chronic listerosis of nude, athymic mice. Thymus. 1987;10(3-4):247–249. [PubMed] [Google Scholar]
  33. Hof H., Gückel H. Lack of synergism of ampicillin and gentamicin in experimental listeriosis. Infection. 1987 Jan-Feb;15(1):40–41. doi: 10.1007/BF01646117. [DOI] [PubMed] [Google Scholar]
  34. Hof H. Listerien--eine Herausforderung für die Diagnostik. Immun Infekt. 1990 Apr;18(2):35–39. [PubMed] [Google Scholar]
  35. Hof H. The effect of coumermycin on experimental listeriosis. J Infect. 1986 Jul;13(1):17–23. doi: 10.1016/s0163-4453(86)92141-9. [DOI] [PubMed] [Google Scholar]
  36. Hof H. Treatment of experimental listeriosis by CI 934, a new quinolone. J Antimicrob Chemother. 1990 Jan;25(1):121–126. doi: 10.1093/jac/25.1.121. [DOI] [PubMed] [Google Scholar]
  37. Hof H. Virulence of different strains of Listeria monocytogenes serovar 1/2a. Med Microbiol Immunol. 1984;173(4):207–218. doi: 10.1007/BF02122112. [DOI] [PubMed] [Google Scholar]
  38. Jack R. W., Tagg J. R., Ray B. Bacteriocins of gram-positive bacteria. Microbiol Rev. 1995 Jun;59(2):171–200. doi: 10.1128/mr.59.2.171-200.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Jones E. M., MacGowan A. P. Antimicrobial chemotherapy of human infection due to Listeria monocytogenes. Eur J Clin Microbiol Infect Dis. 1995 Mar;14(3):165–175. doi: 10.1007/BF02310351. [DOI] [PubMed] [Google Scholar]
  40. Kalstone C. Successful antepartum treatment of listeriosis. Am J Obstet Gynecol. 1991 Jan;164(1 Pt 1):57–58. doi: 10.1016/0002-9378(91)90625-2. [DOI] [PubMed] [Google Scholar]
  41. Kiderlen A. F., Kaufmann S. H., Lohmann-Matthes M. L. Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur J Immunol. 1984 Oct;14(10):964–967. doi: 10.1002/eji.1830141019. [DOI] [PubMed] [Google Scholar]
  42. Kihlström E. Infection of HeLa cells with Salmonella typhimurium 395 MS and MR10 bacteria. Infect Immun. 1977 Aug;17(2):290–295. doi: 10.1128/iai.17.2.290-295.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Kim K. S. In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenes. Antimicrob Agents Chemother. 1986 Feb;29(2):289–293. doi: 10.1128/aac.29.2.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Lavetter A., Leedom J. M., Mathies A. W., Jr, Ivler D., Wehrle P. F. Meningitis due to Listeria monocytogenes. A review of 25 cases. N Engl J Med. 1971 Sep 9;285(11):598–603. doi: 10.1056/NEJM197109092851103. [DOI] [PubMed] [Google Scholar]
  45. Lehrer R. I., Lichtenstein A. K., Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol. 1993;11:105–128. doi: 10.1146/annurev.iy.11.040193.000541. [DOI] [PubMed] [Google Scholar]
  46. Lorber B., Santoro J., Swenson R. M. Letter: Listeria meningitis during cefazolin therapy. Ann Intern Med. 1975 Feb;82(2):226–226. doi: 10.7326/0003-4819-82-2-226_1. [DOI] [PubMed] [Google Scholar]
  47. Louria D. B., Hensle T., Armstrong D., Collins H. S., Blevins A., Krugman D., Buse M. Listeriosis complicating malignant disease. A new association. Ann Intern Med. 1967 Aug;67(2):260–281. doi: 10.7326/0003-4819-67-2-261. [DOI] [PubMed] [Google Scholar]
  48. Loza E., Martínez Beltrán J., Baquero F., León A., Cantón R., Garijo B. Comparative in vitro activity of clarithromycin. Spanish Collaborative Group. Eur J Clin Microbiol Infect Dis. 1992 Sep;11(9):856–866. doi: 10.1007/BF01960892. [DOI] [PubMed] [Google Scholar]
  49. MACKANESS G. B. Cellular resistance to infection. J Exp Med. 1962 Sep 1;116:381–406. doi: 10.1084/jem.116.3.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. MacGowan A. P., Holt H. A., Bywater M. J., Reeves D. S. In vitro antimicrobial susceptibility of Listeria monocytogenes isolated in the UK and other Listeria species. Eur J Clin Microbiol Infect Dis. 1990 Oct;9(10):767–770. doi: 10.1007/BF02184692. [DOI] [PubMed] [Google Scholar]
  51. MacGowan A. P., Holt H. A., Reeves D. S. In-vitro synergy testing of nine antimicrobial combinations against Listeria monocytogenes. J Antimicrob Chemother. 1990 Apr;25(4):561–566. doi: 10.1093/jac/25.4.561. [DOI] [PubMed] [Google Scholar]
  52. Macnair D. R., White J. E., Graham J. M. Ampicillin in the treatment of Listeria monocytogenes meningitis. Lancet. 1968 Jan 6;1(7532):16–17. doi: 10.1016/s0140-6736(68)90007-x. [DOI] [PubMed] [Google Scholar]
  53. Mangi R. J., Kundargi R. S., Quintiliani R., Andriole V. T. Development of meningitis during cephalothin therapy. Ann Intern Med. 1973 Mar;78(3):347–351. doi: 10.7326/0003-4819-78-3-347. [DOI] [PubMed] [Google Scholar]
  54. Marklein G., Häfelein J. Zur Empfindlichkeit in vitro von Listeria monocytogenes unter besonderer Berücksichtigung neuerer Beta-Laktamantibiotika. Zentralbl Bakteriol Mikrobiol Hyg A. 1981 Dec;251(1):40–53. [PubMed] [Google Scholar]
  55. Marquardt D., McCrone S., Center M. S. Mechanisms of multidrug resistance in HL60 cells: detection of resistance-associated proteins with antibodies against synthetic peptides that correspond to the deduced sequence of P-glycoprotein. Cancer Res. 1990 Mar 1;50(5):1426–1430. [PubMed] [Google Scholar]
  56. McCracken G. H., Jr, Nelson J. D., Thomas M. L. Discrepancy between carbenicillin and ampicillin activities against enterococci and Listeria. Antimicrob Agents Chemother. 1973 Mar;3(3):343–349. doi: 10.1128/aac.3.3.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. McLauchlin J., Audurier A., Taylor A. G. Treatment failure and recurrent human listeriosis. J Antimicrob Chemother. 1991 Jun;27(6):851–857. doi: 10.1093/jac/27.6.851. [DOI] [PubMed] [Google Scholar]
  58. Medoff G., Kunz L. J., Weinberg A. N. Listeriosis in humans: an evaluation. J Infect Dis. 1971 Mar;123(3):247–250. doi: 10.1093/infdis/123.3.247. [DOI] [PubMed] [Google Scholar]
  59. Metz P., Hof H., Kathariou S. Inhibitory effect of tetracycline and doxycycline on resistance of mice to infection with a tetracycline-resistant strain of Listeria monocytogenes. Int J Immunopharmacol. 1988;10(5):519–524. doi: 10.1016/0192-0561(88)90068-9. [DOI] [PubMed] [Google Scholar]
  60. Michelet C., Avril J. L., Cartier F., Berche P. Inhibition of intracellular growth of Listeria monocytogenes by antibiotics. Antimicrob Agents Chemother. 1994 Mar;38(3):438–446. doi: 10.1128/aac.38.3.438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Moellering R. C., Jr, Medoff G., Leech I., Wennersten C., Kunz L. J. Antibiotic synergism against Listeria monocytogenes. Antimicrob Agents Chemother. 1972 Jan;1(1):30–34. doi: 10.1128/aac.1.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Mohan K., Gordon R. C., Beaman T. C., Belding R. C., Luecke D., Edmiston C., Gerhardt P. Synergism of penicillin and gentamicin against Listeria monocytogenes in ex vivo hemodialysis culture. J Infect Dis. 1977 Jan;135(1):51–54. doi: 10.1093/infdis/135.1.51. [DOI] [PubMed] [Google Scholar]
  63. Nelson J. D., Shelton S., Parks D. Antibiotic susceptibility of Listeria monocytogenes and treatment of neonatal listeriosis with ampicillin. Acta Paediatr Scand. 1967 Mar;56(2):151–158. doi: 10.1111/j.1651-2227.1967.tb15358.x. [DOI] [PubMed] [Google Scholar]
  64. Neu H. C., Labthavikul P. In vitro activity of teichomycin compared with those of other antibiotics. Antimicrob Agents Chemother. 1983 Sep;24(3):425–428. doi: 10.1128/aac.24.3.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Neumann H., Cavalié A., Jenne D. E., Wekerle H. Induction of MHC class I genes in neurons. Science. 1995 Jul 28;269(5223):549–552. doi: 10.1126/science.7624779. [DOI] [PubMed] [Google Scholar]
  66. Nichterlein T., Kretschmar M., Budeanu C., Bauer J., Linss W., Hof H. Bay Y 3118, a new quinolone derivative, rapidly eradicates Listeria monocytogenes from infected mice and L929 cells. Antimicrob Agents Chemother. 1994 Jul;38(7):1501–1506. doi: 10.1128/aac.38.7.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Nichterlein T., Kretschmar M., Hof H. RP 59500, a streptogramin derivative, is effective in murine listeriosis. J Chemother. 1996 Apr;8(2):107–112. doi: 10.1179/joc.1996.8.2.107. [DOI] [PubMed] [Google Scholar]
  68. Nichterlein T., Kretschmar M., Siegsmund M., Hof H. Erythromycin is ineffective against Listeria monocytogenes in multidrug resistant cells. J Chemother. 1995 Jun;7(3):184–188. doi: 10.1179/joc.1995.7.3.184. [DOI] [PubMed] [Google Scholar]
  69. Nieman R. E., Lorber B. Listeriosis in adults: a changing pattern. Report of eight cases and review of the literature, 1968-1978. Rev Infect Dis. 1980 Mar-Apr;2(2):207–227. doi: 10.1093/clinids/2.2.207. [DOI] [PubMed] [Google Scholar]
  70. Odio C., Thomas M. L., McCracken G. H., Jr Pharmacokinetics and bacteriological efficacy of mezlocillin in experimental Escherichia coli and Listeria monocytogenes meningitis. Antimicrob Agents Chemother. 1984 Apr;25(4):427–432. doi: 10.1128/aac.25.4.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Penn R. L., Ward T. T., Steigbigel R. T. Effects of erythromycin in combination with penicillin, ampicillin, or gentamicin on the growth of Listeria monocytogenes. Antimicrob Agents Chemother. 1982 Aug;22(2):289–294. doi: 10.1128/aac.22.2.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Pierre J., Boisivon A., Gutmann L. Alteration of PBP 3 entails resistance to imipenem in Listeria monocytogenes. Antimicrob Agents Chemother. 1990 Sep;34(9):1695–1698. doi: 10.1128/aac.34.9.1695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Pollock S. S., Pollock T. M., Harrison M. J. Ampicillin-resistant Listeria monocytogenes meningitis. Arch Neurol. 1986 Feb;43(2):106–106. doi: 10.1001/archneur.1986.00520020004004. [DOI] [PubMed] [Google Scholar]
  74. Portnoy D. A., Chakraborty T., Goebel W., Cossart P. Molecular determinants of Listeria monocytogenes pathogenesis. Infect Immun. 1992 Apr;60(4):1263–1267. doi: 10.1128/iai.60.4.1263-1267.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Poyart-Salmeron C., Carlier C., Trieu-Cuot P., Courtieu A. L., Courvalin P. Transferable plasmid-mediated antibiotic resistance in Listeria monocytogenes. Lancet. 1990 Jun 16;335(8703):1422–1426. doi: 10.1016/0140-6736(90)91447-i. [DOI] [PubMed] [Google Scholar]
  76. Poyart-Salmeron C., Trieu-Cuot P., Carlier C., MacGowan A., McLauchlin J., Courvalin P. Genetic basis of tetracycline resistance in clinical isolates of Listeria monocytogenes. Antimicrob Agents Chemother. 1992 Feb;36(2):463–466. doi: 10.1128/aac.36.2.463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Pucci M. J., Vedamuthu E. R., Kunka B. S., Vandenbergh P. A. Inhibition of Listeria monocytogenes by using bacteriocin PA-1 produced by Pediococcus acidilactici PAC 1.0. Appl Environ Microbiol. 1988 Oct;54(10):2349–2353. doi: 10.1128/aem.54.10.2349-2353.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Quentin C., Thibaut M. C., Horovitz J., Bebear C. Multiresistant strain of Listeria monocytogenes in septic abortion. Lancet. 1990 Aug 11;336(8711):375–375. doi: 10.1016/0140-6736(90)91916-x. [DOI] [PubMed] [Google Scholar]
  79. Raoult D., Drancourt M., Vestris G. Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells. Antimicrob Agents Chemother. 1990 Aug;34(8):1512–1514. doi: 10.1128/aac.34.8.1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Rapp M. F., Pershadsingh H. A., Long J. W., Jr, Pickens J. M. Ampicillin-resistant Listeria monocytogenes meningitis in a previously healthy 14-year-old athlete. Arch Neurol. 1984 Dec;41(12):1304–1304. doi: 10.1001/archneur.1984.04050230090030. [DOI] [PubMed] [Google Scholar]
  81. Reynaud A., Espaze E. P., Papin S., Courtieu A. L. Etude de la sensibilité aux antibiotiques de 139 souches de Listeria sérotypées par le Centre National de Référence en 1983. Ann Microbiol (Paris) 1984 Nov-Dec;135B(3):331–339. [PubMed] [Google Scholar]
  82. Sanchez M. L., Wenzel R. P., Jones R. N. In vitro activity of decaplanin (M86-1410), a new glycopeptide antibiotic. Antimicrob Agents Chemother. 1992 Apr;36(4):873–875. doi: 10.1128/aac.36.4.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Sande M. A. Factors influencing the penetration and activity of antibiotics in experimental meningitis. J Infect. 1981 Mar;3(1 Suppl):33–38. doi: 10.1016/s0163-4453(81)80006-0. [DOI] [PubMed] [Google Scholar]
  84. Satta G., Cornaglia G., Mazzariol A., Golini G., Valisena S., Fontana R. Target for bacteriostatic and bactericidal activities of beta-lactam antibiotics against Escherichia coli resides in different penicillin-binding proteins. Antimicrob Agents Chemother. 1995 Apr;39(4):812–818. doi: 10.1128/aac.39.4.812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Scheld W. M., Fletcher D. D., Fink F. N., Sande M. A. Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes. J Infect Dis. 1979 Sep;140(3):287–294. doi: 10.1093/infdis/140.3.287. [DOI] [PubMed] [Google Scholar]
  86. Schillinger U., Kaya M., Lücke F. K. Behaviour of Listeria monocytogenes in meat and its control by a bacteriocin-producing strain of Lactobacillus sake. J Appl Bacteriol. 1991 Jun;70(6):473–478. doi: 10.1111/j.1365-2672.1991.tb02743.x. [DOI] [PubMed] [Google Scholar]
  87. Schlüter D., Chahoud S., Lassmann H., Schumann A., Hof H., Deckert-Schlüter M. Intracerebral targets and immunomodulation of murine Listeria monocytogenes meningoencephalitis. J Neuropathol Exp Neurol. 1996 Jan;55(1):14–24. doi: 10.1097/00005072-199601000-00002. [DOI] [PubMed] [Google Scholar]
  88. Schmitt-Slomska J., Marmouset M. C., Louis C., Bally R., Starka G., Madoff S. Tetracycline-resistant L-forms isolated from an antibiotic-susceptible strain of Listeria monocytogenes. Antimicrob Agents Chemother. 1982 Oct;22(4):678–685. doi: 10.1128/aac.22.4.678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Seeliger H. P., Laymann U., Finger H. Untersuchungen zur Frage der Wirksamkeit von Ampicillin auf Listeria monocytogenes. Dtsch Med Wochenschr. 1967 Jun 16;92(24):1095–1097. doi: 10.1055/s-0028-1103746. [DOI] [PubMed] [Google Scholar]
  90. Selsted M. E., Szklarek D., Lehrer R. I. Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun. 1984 Jul;45(1):150–154. doi: 10.1128/iai.45.1.150-154.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Seoh S. A., Busath D. The permeation properties of small organic cations in gramicidin A channels. Biophys J. 1993 Apr;64(4):1017–1028. doi: 10.1016/S0006-3495(93)81467-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Sheehan B., Kocks C., Dramsi S., Gouin E., Klarsfeld A. D., Mengaud J., Cossart P. Molecular and genetic determinants of the Listeria monocytogenes infectious process. Curr Top Microbiol Immunol. 1994;192:187–216. doi: 10.1007/978-3-642-78624-2_9. [DOI] [PubMed] [Google Scholar]
  93. Siragusa G. R., Cutter C. N. Brochocin-C, a new bacteriocin produced by Brochothrix campestris. Appl Environ Microbiol. 1993 Jul;59(7):2326–2328. doi: 10.1128/aem.59.7.2326-2328.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Skogberg K., Syrjänen J., Jahkola M., Renkonen O. V., Paavonen J., Ahonen J., Kontiainen S., Ruutu P., Valtonen V. Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin Infect Dis. 1992 Apr;14(4):815–821. doi: 10.1093/clinids/14.4.815. [DOI] [PubMed] [Google Scholar]
  95. Slade P. J., Collins-Thompson D. L. Listeria, plasmids, antibiotic resistance, and food. Lancet. 1990 Oct 20;336(8721):1004–1004. doi: 10.1016/0140-6736(90)92464-s. [DOI] [PubMed] [Google Scholar]
  96. Spitzer P. G., Hammer S. M., Karchmer A. W. Treatment of Listeria monocytogenes infection with trimethoprim-sulfamethoxazole: case report and review of the literature. Rev Infect Dis. 1986 May-Jun;8(3):427–430. doi: 10.1093/clinids/8.3.427. [DOI] [PubMed] [Google Scholar]
  97. Testa R. T., Petersen P. J., Jacobus N. V., Sum P. E., Lee V. J., Tally F. P. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines. Antimicrob Agents Chemother. 1993 Nov;37(11):2270–2277. doi: 10.1128/aac.37.11.2270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Thiebaut F., Tsuruo T., Hamada H., Gottesman M. M., Pastan I., Willingham M. C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7735–7738. doi: 10.1073/pnas.84.21.7735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Tilney L. G., Tilney M. S. The wily ways of a parasite: induction of actin assembly by Listeria. Trends Microbiol. 1993 Apr;1(1):25–31. doi: 10.1016/0966-842x(93)90021-i. [DOI] [PubMed] [Google Scholar]
  100. Tuazon C. U., Shamsuddin D., Miller H. Antibiotic susceptibility and synergy of clinical isolates of Listeria monocytogenes. Antimicrob Agents Chemother. 1982 Mar;21(3):525–527. doi: 10.1128/aac.21.3.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Van der Auwera P., Grenier P., Klastersky J. In-vitro activity of LY146032 against Staphylococcus aureus, Listeria monocytogenes, Corynebacterium JK, and Bacillus spp., in comparison with various antibiotics. J Antimicrob Chemother. 1987 Aug;20(2):209–212. doi: 10.1093/jac/20.2.209. [DOI] [PubMed] [Google Scholar]
  102. Vicente M. F., Pérez-Dáz J. C., Baquero F., Angel de Pedro M., Berenguer J. Penicillin-binding protein 3 of Listeria monocytogenes as the primary lethal target for beta-lactams. Antimicrob Agents Chemother. 1990 Apr;34(4):539–542. doi: 10.1128/aac.34.4.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Vischer W. A., Rominger C. Rifampicin against experimental listeriosis in the mouse. Chemotherapy. 1978;24(2):104–111. doi: 10.1159/000237768. [DOI] [PubMed] [Google Scholar]
  104. Vogt P., Schorn T., Frei U. Ofloxacin in the treatment of urinary tract infection in renal transplant recipients. Infection. 1988 May-Jun;16(3):175–178. doi: 10.1007/BF01644096. [DOI] [PubMed] [Google Scholar]
  105. Weingärtner L., Ortel S. Zur Behandlung der Listeriose mit Ampicillin. Dtsch Med Wochenschr. 1967 Jun 16;92(24):1098–1104. doi: 10.1055/s-0028-1103747. [DOI] [PubMed] [Google Scholar]
  106. Wiggins G. L., Albritton W. L., Feeley J. C. Antibiotic susceptibility of clinical isolates of Listeria monocytogenes. Antimicrob Agents Chemother. 1978 May;13(5):854–860. doi: 10.1128/aac.13.5.854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Winslow D. L., Damme J., Dieckman E. Delayed bactericidal activity of beta-lactam antibiotics against Listeria monocytogenes: antagonism of chloramphenicol and rifampin. Antimicrob Agents Chemother. 1983 Apr;23(4):555–558. doi: 10.1128/aac.23.4.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Winslow D. L., Pankey G. A. In vitro activities of trimethoprim and sulfamethoxazole against Listeria monocytogenes. Antimicrob Agents Chemother. 1982 Jul;22(1):51–54. doi: 10.1128/aac.22.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Winslow D. L., Steele M. L. Listeria bacteremia and peritonitis associated with a peritoneovenous shunt: successful treatment with sulfamethoxazole and trimethoprim. J Infect Dis. 1984 May;149(5):820–820. doi: 10.1093/infdis/149.5.820. [DOI] [PubMed] [Google Scholar]
  110. Yersin B. R., Glauser M. P., Regli F. Infections à Listeria monocytogenes chez l'adulte. Etude de 10 cas et revue de la littérature. Schweiz Med Wochenschr. 1981 Oct 24;111(43):1596–1602. [PubMed] [Google Scholar]
  111. van Laack R. L., Schillinger U., Holzapfel W. H. Characterization and partial purification of a bacteriocin produced by Leuconostoc carnosum LA44A. Int J Food Microbiol. 1992 Jul;16(3):183–195. doi: 10.1016/0168-1605(92)90079-i. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES